Dec 15, 2014 02:51 PM EST
German drugmakers including Stada, Torrent's Heumann and Dr. Reddy's betapharm have appealed a regulator's decision to suspend approval of some drugs over concerns about clinical trials conducted by an Indian company.
Regulators in France, Germany, Belgium and Luxembourg this month suspended marketing approval for 25 drugs over the quality of trial data from India's GVK Biosciences.
Companies that have filed an appeal will be allowed to resume sales of affected products until their appeals are either approved or struck down, Germany's Federal Institute for Drugs and Medical Devices (BfArM) said on Monday.
"We are reviewing the appeals thoroughly and quickly," a spokesman for BfArM said.
The regulator last week had published a list of 80 affected products that their manufacturers would not be allowed to sell until they had provided new clinical data.
2. Sep 17, 2018
Study: Earth's oldest animals formed complex ecological communities
3. Aug 21, 2018
Study: Length of opioid prescription spell highest risk for misuse after surgery
4. Aug 06, 2018
NASA Introduces First Batch Of Commercial Astronaut Crew
2. Jul 26, 2018
Researchers develop a new method to detect nucleation
3. Jul 26, 2018
New system can identify drugs to target 'undruggable' enzymes critical in many diseases
4. Jul 26, 2018
Health benefits of moderate drinking may be overstated, study finds